SCHEMBL13110212

SCHEMBL13110212

CCOC(=O)c1cc2c(/C=C/c3cccc(OC)c3)nc(N)nc2s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 4/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ MAPT P10636 5/20 0.43
▸ HCRTR1 O43613 1/20 0.41
▸ TP53 P04637 2/20 0.40
▸ DHFR P00374 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ CYP19A1 P11511 1/20 0.40
▸ KDM4E B2RXH2 4/20 0.39
▸ MAOB P27338 2/20 0.39
▸ ADORA2A P29274 2/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ ADORA1 P30542 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3322538 0.88 GRM4 (0.46) HPGDALDH1A1HSD17B10ALOX15MAPT
SCHEMBL3322543 0.88 GRM4 (0.46) HPGDALDH1A1HSD17B10ALOX15MAPT
SCHEMBL13110217 0.85 MAPT (0.43) HPGDALDH1A1MAPTTP53MAOB
SCHEMBL13110215 0.82 HSP90AB1 (0.47) HPGDALDH1A1MAPTKDM4EKMT2A
SCHEMBL13110216 0.82 MAPK14 (0.44) HPGDALDH1A1MAPTKDM4EMEN1
SCHEMBL13110228 0.81 HSP90AB1 (0.42) HPGDALDH1A1HSD17B10MAPTKDM4E
SCHEMBL13126247 0.81 HSP90AB1 (0.42) HPGDALDH1A1HSD17B10MAPTKDM4E
SCHEMBL13110222 0.80 MEN1 (0.41) MAPTKDM4EMAOBADORA1MEN1
SCHEMBL13110229 0.79 HSP90AB1 (0.43) HPGDALDH1A1HSD17B10MAPTKDM4E
SCHEMBL13110223 0.79 HSP90AB1 (0.40) HPGDALDH1A1HSD17B10MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8642594-B2 Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors VERNALIS (R&D) LIMITED (GB) 2014-02-04 — — US disclosed
US-8642594-B2 Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors VERNALIS (R&D) LIMITED (GB) 2014-02-04 — — US disclosed
US-7820658-B2 Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors VERNALIS (CAMBRIDGE) LIMITED (GB) 2010-10-26 — — US disclosed
US-7820658-B2 Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors VERNALIS (CAMBRIDGE) LIMITED (GB) 2010-10-26 — — US disclosed
US-20100120767-A1 Pyrimidothiophene Compounds Barril-Alonso, Xavier (GB) 2010-05-13 — — US disclosed
US-20100120767-A1 Pyrimidothiophene Compounds Barril-Alonso, Xavier (GB) 2010-05-13 — — US disclosed
US-20070043044-A1 Pyrimidothiophene compounds VERNALIS (CAMBRIDGE) LIMITED (GB) 2007-02-22 — — US disclosed
US-20070043044-A1 Pyrimidothiophene compounds VERNALIS (CAMBRIDGE) LIMITED (GB) 2007-02-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120767-A1 Pyrimidothiophene Compounds ALK, HSP90AA1, HSP90AB1 HPGD 2963/4885ALDH1A1 83/4885HSD17B10 566/4885
US-20070043044-A1 Pyrimidothiophene compounds ALK, HSP90AA1, HSP90AB1 HPGD 3012/4885ALDH1A1 91/4885HSD17B10 635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback